Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

Introduction: Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is available to comprehensively evaluate the role of delamanid (DLM), we evaluated its effectiveness and safety. Methods: We reviewe...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Mohammad Javad Nasiri, Moein Zangiabadian, Erfan Arabpour, Sirus Amini, Farima Khalili, Rosella Centis, Lia D'Ambrosio, Justin T. Denholm, H. Simon Schaaf, Martin van den Boom, Xhevat Kurhasani, Margareth Pretti Dalcolmo, Seif Al-Abri, Jeremiah Chakaya, Jan-Willem Alffenaar, Onno Akkerman, Denise Rossato Silva, Marcela Muňoz-Torrico, Barbara Seaworth, Emanuele Pontali, Laura Saderi, Simon Tiberi, Alimuddin Zumla, Giovanni Battista Migliori, Giovanni Sotgiu
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2022-11-01
Ráidu:	International Journal of Infectious Diseases
Fáttát:	TB MDR-TB delamanid bedaquiline effectiveness safety
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S1201971222001254
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!